X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
71
PharmaCompass offers a list of Levamisole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levamisole manufacturer or Levamisole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levamisole manufacturer or Levamisole supplier.
PharmaCompass also assists you with knowing the Levamisole API Price utilized in the formulation of products. Levamisole API Price is not always fixed or binding as the Levamisole Price is obtained through a variety of data sources. The Levamisole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levamisole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levamisole, including repackagers and relabelers. The FDA regulates Levamisole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levamisole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levamisole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levamisole supplier is an individual or a company that provides Levamisole active pharmaceutical ingredient (API) or Levamisole finished formulations upon request. The Levamisole suppliers may include Levamisole API manufacturers, exporters, distributors and traders.
click here to find a list of Levamisole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levamisole DMF (Drug Master File) is a document detailing the whole manufacturing process of Levamisole active pharmaceutical ingredient (API) in detail. Different forms of Levamisole DMFs exist exist since differing nations have different regulations, such as Levamisole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levamisole DMF submitted to regulatory agencies in the US is known as a USDMF. Levamisole USDMF includes data on Levamisole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levamisole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levamisole suppliers with USDMF on PharmaCompass.
A Levamisole CEP of the European Pharmacopoeia monograph is often referred to as a Levamisole Certificate of Suitability (COS). The purpose of a Levamisole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levamisole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levamisole to their clients by showing that a Levamisole CEP has been issued for it. The manufacturer submits a Levamisole CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levamisole CEP holder for the record. Additionally, the data presented in the Levamisole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levamisole DMF.
A Levamisole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levamisole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levamisole suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levamisole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levamisole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levamisole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levamisole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levamisole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levamisole suppliers with NDC on PharmaCompass.
Levamisole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levamisole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levamisole GMP manufacturer or Levamisole GMP API supplier for your needs.
A Levamisole CoA (Certificate of Analysis) is a formal document that attests to Levamisole's compliance with Levamisole specifications and serves as a tool for batch-level quality control.
Levamisole CoA mostly includes findings from lab analyses of a specific batch. For each Levamisole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levamisole may be tested according to a variety of international standards, such as European Pharmacopoeia (Levamisole EP), Levamisole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levamisole USP).
Market Place
